VVD-118313
Overview of the experimental drug VVD-118313
VVD-118313[edit]
VVD-118313 is an experimental drug that has been investigated for its potential therapeutic effects in the treatment of various neurological disorders. It is a small molecule that acts as a selective antagonist of the 5-HT6 receptor, a subtype of the serotonin receptor family. The compound was developed with the aim of improving cognitive function and has been studied primarily in the context of Alzheimer's disease and other forms of dementia.
Pharmacology[edit]
VVD-118313 functions by selectively binding to and inhibiting the activity of the 5-HT6 receptor. This receptor is predominantly expressed in the central nervous system, particularly in regions of the brain associated with learning and memory, such as the hippocampus and cortex. By blocking the 5-HT6 receptor, VVD-118313 is thought to enhance the release of neurotransmitters like acetylcholine, dopamine, and glutamate, which play crucial roles in cognitive processes.
Mechanism of Action[edit]
The 5-HT6 receptor is a G protein-coupled receptor (GPCR) that is positively coupled to adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels when activated. By antagonizing this receptor, VVD-118313 reduces cAMP production, which in turn modulates neurotransmitter release and neuronal signaling pathways. This modulation is believed to contribute to the cognitive-enhancing effects observed in preclinical studies.
Potential Therapeutic Applications[edit]
VVD-118313 has been primarily investigated for its potential use in treating cognitive deficits associated with Alzheimer's disease. Preclinical studies have shown that the compound can improve performance in animal models of memory impairment. Additionally, there is interest in exploring its use in other conditions characterized by cognitive dysfunction, such as schizophrenia and Parkinson's disease.
Development and Research[edit]
The development of VVD-118313 is part of a broader effort to create novel treatments for cognitive disorders by targeting the serotonergic system. While the compound has shown promise in early-stage research, further studies are needed to fully understand its efficacy and safety profile in humans. Clinical trials are necessary to determine the optimal dosing, potential side effects, and long-term benefits of VVD-118313.
Related pages[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
